- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03326349
Home-based Computerized Cognitive Rehabilitation in Chronic Stage Stroke (CHRONIC)
May 17, 2019 updated by: Josep M. Tormos Muñoz
This study evaluates the effectiveness of Guttmann NeuroPersonalTrainer (GNPT), a tele-rehabilitation platform developed as a tool for the cognitive rehabilitation of chronic stroke patients.
All patients will receive this treatment but in different order: half will receive GNPT and the other half will receive sham cognitive training; after a washout period of three months, crossover will occur and participants from the GNPT condition will receive sham cognitive training, while participants originally from the control intervention will receive GNPT.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08916
- Institut Guttmann
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- to be over 18 years old,
- to have been diagnosed with stroke
- an occurrence of the injury of 12 month period ore more (chronic stage)
- cognitive impairment confirmed by pre-intervention neuropsychological assessment
Exclusion Criteria:
- diagnosis of language deficits or aphasia
- motor impairment concerning upper limbs that may incapacitate them for the use of the computer
- severe alteration of the visual field or perceptual problems
- health status that may require further intervention or admission to a medical center during the study;
- neurological or psychiatric history
- substance abuse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Guttmann, NeuroPersonalTrainer
Guttmann NeuroPersonalTrainer (GNPT) 5 days per week over 6 weeks.
|
Guttmann NeuroPersonalTrainer (GNPT) is a telerehabilitation platform.
GNPT consists of a set of computerized cognitive exercises covering different cognitive functions and subfunctions.
Every task has been specifically based on cognitive paradigms to address specific cognitive subfunction.
The rehabilitation process starts by assigning a patient to a therapist responsible for the treatment.
The therapist has then to perform the initial neuropsychological assessment, consisting of a set of validated tests used to attention, memory and executive functions prior to the treatment.
The results of these tests will be stored in GNPT system.
Then, the cognitive profile is calculated using these results, and taking into account the patient's age and study level.
Using this profile, the program assigns a set of computerized tasks to a certain day, configuring the input parameters of each task in order to personalize treatments.
|
|
Sham Comparator: Ictus.online
Itus.online 5 days per week over 6 weeks
|
An online domain which provides a daily session of one hour of duration.
Each session consists of four ten-minute videos.
After each video, the participant must complete a three-question quiz about the contents of the video (for example, "What animal appears in in the video?").
The difficulty level is minimal, and does not vary depending on the execution of the participant.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conners Continuous Performance Test (CPT-II)
Time Frame: 1 day
|
To improve performance in sustained attention after receiving experimental intervention.
|
1 day
|
|
Rey Auditory Verbal Learning Test (RAVLT)
Time Frame: 1 day
|
To improve performance in short-term, long-term and recognition.
This test has puntuation range from 0 to 75.
|
1 day
|
|
Spanish phonemic fluency test- PMR
Time Frame: 1 day
|
To improve performance in phonemic fluency after receiving experimental intervention.
|
1 day
|
|
Digit Span forward Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
|
To improve performance in span of immediate verbal recall after receiving experimental intervention.
This subtest has a puntuation range from 2 to 9, where higher values are considered to be a better outcome.
|
1 day
|
|
Digit Span backward Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
|
To improve performance in working memory after receiving experimental intervention.
This subtest has a puntuation range from 2 to 8, where higher values are considered to be a better outcome.
|
1 day
|
|
Letter-Number Sequencing Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
|
To improve performance in working memory after receiving experimental intervention.
This subtest has a puntation range from 1 to 21, where higher values are considered to be a better outcome.
|
1 day
|
|
Rating Scale for Attentional Behavior (RSAB)
Time Frame: 1 week
|
RSAB comprises 14 items aimed to identify attentional difficulties on daily routines
|
1 week
|
|
Prospective and Retrospective Memory Questionnaire (PRMQ)
Time Frame: 1 week
|
PRMQ includes 16 items designed to evaluate prospective and retrospective memory in short- and long-term
|
1 week
|
|
Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)
Time Frame: 1 week
|
BRIEF-A includes 75 items designed to assess executive function behaviors on day-to-day activities.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Digit Symbol-Coding Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
|
To improve performance in speed of processing.
This subtest has a puntuation range from 1 to 133, where higher values are considered to be a better outcome.
|
1 day
|
|
Block Design Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
|
To improve performance in visuoconstruction and planning.
This subtest has a puntuation range from 1 to 68, where higher values are considered to be a better outcome.
|
1 day
|
|
Stroop Color and Word test (Stroop Test)
Time Frame: 1 day
|
To improve performance in inhibitory control
|
1 day
|
|
Trail Making Test A (TMT-A)
Time Frame: 1 day
|
To improve performance in visual attention
|
1 day
|
|
Trail Making Test B (TMT-B)
Time Frame: 1 day
|
To improve performance in task-switching
|
1 day
|
|
Wisconsin Card Sorting Test (WCST)
Time Frame: 1day
|
To improve performance in cognitive flexibility
|
1day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.
- Gil-Pages M, Solana J, Sanchez-Carrion R, Tormos JM, Ensenat-Cantallops A, Garcia-Molina A. A customized home-based computerized cognitive rehabilitation platform for patients with chronic-stage stroke: study protocol for a randomized controlled trial. Trials. 2018 Mar 22;19(1):191. doi: 10.1186/s13063-018-2577-8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 17, 2017
Primary Completion (Actual)
February 4, 2019
Study Completion (Actual)
May 7, 2019
Study Registration Dates
First Submitted
October 26, 2017
First Submitted That Met QC Criteria
October 26, 2017
First Posted (Actual)
October 31, 2017
Study Record Updates
Last Update Posted (Actual)
May 21, 2019
Last Update Submitted That Met QC Criteria
May 17, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016251
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
University of EdinburghNHS LothianNot yet recruitingCognitive Impairment | Anesthesia | Cognitive Impairment, Mild | Anesthesia Brain Monitoring | Cognitive Impairment, Progressive | Anesthesia Depth MonitoringUnited Kingdom
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaRecruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive ImpairmentSpain
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
Sunnybrook Health Sciences CentreRecruitingMild Cognitive Impairment | Vascular Cognitive ImpairmentCanada
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University of HawaiiRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
Clinical Trials on Guttmann, NeuroPersonalTrainer
-
Institut GuttmannUnknownCognitive Impairment | Traumatic Brain InjurySpain